Metvix for Basal cell carcinoma
Quick answer: Metvix is used for Basal cell carcinoma as part of a photosensitizing agent (topical) treatment regimen. Methyl aminolevulinate is converted to protoporphyrin IX in cells, enabling photodynamic destruction upon light exposure The specific dosing for Basal cell carcinoma is determined by your prescriber based on individual factors.
Why is Metvix used for Basal cell carcinoma?
Metvix belongs to the Photosensitizing agent (topical) class. Methyl aminolevulinate is converted to protoporphyrin IX in cells, enabling photodynamic destruction upon light exposure This action makes it useful for treating or managing Basal cell carcinoma in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Metvix is the right choice for a specific patient depends on the type and severity of Basal cell carcinoma, response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for Basal cell carcinoma
Common adult dosing range: 160 mg/g cream applied topically before red-light illumination. The actual dose for Basal cell carcinoma depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Metvix medicine page.
What to expect
Metvix treatment for Basal cell carcinoma typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on Basal cell carcinoma
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Metvix is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all Photosensitizing agent (topical) for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Metvix
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Metvix full prescribing information · All Photosensitizing agent (topical) alternatives
Frequently asked questions
How effective is Metvix for Basal cell carcinoma?
Effectiveness varies by individual response, dose, and severity. Metvix is one of several treatment options for Basal cell carcinoma, supported by clinical evidence within the photosensitizing agent (topical) class. Discuss expected response with your prescriber.
How long do I need to take Metvix for Basal cell carcinoma?
Treatment duration depends on the nature of Basal cell carcinoma — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Metvix when used for Basal cell carcinoma?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Metvix for Basal cell carcinoma?
Yes. Multiple medicines and non-drug options exist for Basal cell carcinoma. Alternatives within the photosensitizing agent (topical) class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.